🧫
cGAS/STING pathway validation in TDP-43 mutant mice
active
experiment
Created: 2026-04-06T12:28:40
By: experiment_extractor
Quality:
85%
✓ SciDEX
ID: experiment-exp-9611670e-a7a5-48cc-a6cc-6
🧫 Experiment Protocol
Animal Modelproposed
Related Entities
▸Metadata
| _origin | {'url': None, 'type': 'internal', 'tracked_at': '2026-04-06T12:28:40.561170'} |
| p_value | None |
| protocol | TDP-43 mutant mouse generation, cGAS/STING inhibition via pharmacologic or genetic approaches, inflammatory marker analysis, behavioral and pathological assessments |
| effect_size | None |
| sample_size | None |
| source_pmid | 33031745 |
| extracted_at | 2026-04-06T05:28:40.538776 |
| _schema_version | 1 |
| experiment_type | animal_model |
| success_criteria | Significant reduction in inflammatory markers and improved neurological outcomes with cGAS/STING pathway inhibition |
| expected_outcomes | cGAS/STING inhibition should prevent TDP-43-induced neuroinflammatory responses and potentially ameliorate disease progression |
| statistical_methods | None |
📊 Evidence Profile
Foundational
Evidence Balance
+0%
Certainty
100%
Debates
0
Incoming
47
Outgoing
53
0 supporting
0 contradicting
0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.